These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

811 related items for PubMed ID: 3262710

  • 1. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
    Itoh K, Platsoucas CD, Balch CM.
    J Exp Med; 1988 Oct 01; 168(4):1419-41. PubMed ID: 3262710
    [Abstract] [Full Text] [Related]

  • 2. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN, Dedoussis GV, Papadopoulos NG, Missitzis I, Stathopoulos GP, Papamichail M.
    Cancer; 1994 Aug 15; 74(4):1275-82. PubMed ID: 7914469
    [Abstract] [Full Text] [Related]

  • 3. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Herlyn M, Parmiani G, Anichini A.
    J Exp Med; 1993 Oct 01; 178(4):1231-46. PubMed ID: 8376931
    [Abstract] [Full Text] [Related]

  • 4. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
    Gervois N, Heuze F, Diez E, Jotereau F.
    Eur J Immunol; 1990 Apr 01; 20(4):825-31. PubMed ID: 1971794
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
    Wong JT, Pinto CE, Gifford JD, Kurnick JT, Kradin RL.
    J Immunol; 1989 Nov 15; 143(10):3404-11. PubMed ID: 2509557
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation by interleukin-4 and interferon-gamma of an autologous melanoma-specific cytotoxic T-cell clone and the tumor-infiltrating lymphocytes from which it was established.
    Yamada T, Holmes EC, Golub SH.
    Cancer Commun; 1990 Nov 15; 2(3):113-21. PubMed ID: 2114166
    [Abstract] [Full Text] [Related]

  • 7. Lymphokine production by human melanoma tumor-infiltrating lymphocytes.
    Salmeron MA, Morita T, Seki H, Platsoucas CD, Itoh K.
    Cancer Immunol Immunother; 1992 Nov 15; 35(3):211-7. PubMed ID: 1386286
    [Abstract] [Full Text] [Related]

  • 8. Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): activation by autologous tumour cell alone.
    Katano M, Nagumo F, Kubota E, Yamamoto H, Matsuo T, Hisatsugu T, Tadano J.
    Biotherapy; 1993 Nov 15; 6(1):25-32. PubMed ID: 8507542
    [Abstract] [Full Text] [Related]

  • 9. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines.
    Schendel DJ, Gansbacher B, Oberneder R, Kriegmair M, Hofstetter A, Riethmüller G, Segurado OG.
    J Immunol; 1993 Oct 15; 151(8):4209-20. PubMed ID: 8409397
    [Abstract] [Full Text] [Related]

  • 10. Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCC.
    Hayakawa K, Salmeron MA, Parkinson DR, Markowitz AB, von Eschenbach AC, Legha SS, Balch CM, Ross MI, Augustus LB, Itoh K.
    J Immunother (1991); 1991 Oct 15; 10(5):313-25. PubMed ID: 1790139
    [Abstract] [Full Text] [Related]

  • 11. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
    Mukherji B, Guha A, Chakraborty NG, Sivanandham M, Nashed AL, Sporn JR, Ergin MT.
    J Exp Med; 1989 Jun 01; 169(6):1961-76. PubMed ID: 2471770
    [Abstract] [Full Text] [Related]

  • 12. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H, Narumi K, Stewart CC, Arbuck SG, Foon KA, Goldrosen MH.
    Anticancer Res; 1992 Jun 01; 12(6B):1925-33. PubMed ID: 1295440
    [Abstract] [Full Text] [Related]

  • 13. HLA-B-restricted, CD8+ cytolytic human T cell clones derived from a melanoma-invaded lymph node.
    Nakashima M, Watanabe T, Koprowski H, Steplewski Z.
    Hybridoma; 1996 Apr 01; 15(2):147-54. PubMed ID: 8743295
    [Abstract] [Full Text] [Related]

  • 14. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors.
    Heo DS, Whiteside TL, Kanbour A, Herberman RB.
    J Immunol; 1988 Jun 01; 140(11):4042-9. PubMed ID: 3286766
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
    Itoh K, Tilden AB, Balch CM.
    Cancer Res; 1986 Jun 01; 46(6):3011-7. PubMed ID: 3486040
    [Abstract] [Full Text] [Related]

  • 16. Augmentation of interleukin-2-induced activation of human melanoma tumor-infiltrating lymphocytes by heteroconjugate antibody.
    Mansfield PF, Rosenblum MG, Murray JL, Itoh K.
    Cancer Immunol Immunother; 1991 Jun 01; 33(4):247-54. PubMed ID: 1829394
    [Abstract] [Full Text] [Related]

  • 17. Proliferation, phenotype, and cytotoxicity of human lymphocytes isolated from lymph nodes invaded by melanoma cells.
    Nakashima M, Janiszewska M, Steplewski Z, Watanabe T, Schuchter L, Koprowski H.
    Hybridoma; 1994 Jun 01; 13(3):241-6. PubMed ID: 7927369
    [Abstract] [Full Text] [Related]

  • 18. Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.
    Pandolfino MC, Viret C, Gervois N, Guilloux Y, Davodeau F, Diez E, Jotereau F.
    Eur J Immunol; 1992 Jul 01; 22(7):1795-802. PubMed ID: 1623924
    [Abstract] [Full Text] [Related]

  • 19. Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture.
    Ciccone E, Viale O, Bottino C, Pende D, Migone N, Casorati G, Tambussi G, Moretta A, Moretta L.
    J Exp Med; 1988 Apr 01; 167(4):1517-22. PubMed ID: 2965741
    [Abstract] [Full Text] [Related]

  • 20. T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients.
    Pandolfi F, Boyle LA, Trentin L, Oliva A, Kurnick JT.
    Clin Exp Immunol; 1994 Jan 01; 95(1):141-7. PubMed ID: 8287599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.